Bionoid Pharma Inc. (BINP)
USD 0.29
(104.23%)
USD 0.29
(104.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2013 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 230.00 | -20.64 Thousand | -19.25 Thousand | -46.55 Thousand | 67.4 Thousand | -357.62 |
| Net Income | -7805.00 | 1478.00 | -135.25 Thousand | -455.78 Thousand | 27.14 Thousand | -1622.95 |
| Depreciation & Amortization | 3000.00 | 3000.00 | 3000.00 | 3000.00 | 3000.00 | 3.31 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 5035.00 | -25.12 Thousand | -30.06 Thousand | - | - | 60.19 |
| Other non-cash items | 10.49 Thousand | 8606.00 | 100.2 Thousand | 412.23 Thousand | 43.25 Thousand | 1201.82 |
| Investing Cash Flow | - | - | 24.97 Thousand | - | - | -24.20 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | -24.20 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 24.97 Thousand | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -50.00 | 16.79 Thousand | 47.04 Thousand | -113.64 Thousand | 323.15 |
| Debt repayment | - | -50.00 | -16.79 Thousand | -50 Thousand | - | -39.62 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -169.81 Thousand | - |
| Common Stock Issuance | - | - | - | - | 56.17 Thousand | - |
| Other Financing Activities | - | - | - | -2951.00 | - | 362.78 |
| Accounts receivables | - | - | 41.75 Thousand | - | - | -0.56 |
| Accounts payables | -4499.00 | -2606.00 | 7103.00 | - | - | - |
| Inventory | - | - | -41.75 Thousand | - | - | 12.34 |
| Other working capital | 9534.00 | -22.51 Thousand | -37.16 Thousand | - | - | 48.42 |
| Cash at beginning of period | 2455.00 | 23.15 Thousand | 630.00 | 135.00 | -124.00 | 84.86 |
| Cash at end of period | 2686.00 | 2455.00 | 23.15 Thousand | 630.00 | 135.00 | 26.20 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 1.00 | - | - | - |
| Net cash flow / Change in cash | 231.00 | -20.69 Thousand | 22.52 Thousand | 495.00 | 259.00 | -58.67 |
| Free Cash Flow | 230.00 | -20.64 Thousand | -19.25 Thousand | -46.55 Thousand | 67.4 Thousand | -357.62 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3573.00 | -397.00 | -21.05 Thousand | -7805.00 | -1567.00 | 12.31 Thousand |
| Depreciation & Amortization | 750.00 | 750.00 | 750.00 | 3000.00 | 750.00 | 750.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3436.00 | -885.00 | 17.07 Thousand | 5035.00 | 3505.00 | -10.65 Thousand |
| Other non-cash items | -1936.00 | 1500.00 | 1502.00 | 10.49 Thousand | 1499.00 | 1983.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3436.00 | - | -1.00 | -4499.00 | - | -483.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | -885.00 | 17.07 Thousand | 9534.00 | 3505.00 | -10.17 Thousand |
| Cash at beginning of period | 2154.00 | 2686.00 | 5908.00 | 2455.00 | 3221.00 | 820.00 |
| Cash at end of period | 2767.00 | 2154.00 | 2686.00 | 2686.00 | 5908.00 | 3221.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 613.00 | -532.00 | -3222.00 | 231.00 | 2687.00 | 2401.00 |
| Free Cash Flow | 613.00 | -532.00 | -3223.00 | 230.00 | 2687.00 | 2401.00 |
9539
000962
FJHL
RTNTF
NBX
0637